Careers

A Career with Purpose

We enable scientific discoveries that make a difference! Our company is a global highly cross-functional team spanning across R&D, Operations, Technology and AI, US and International Sales, Global Marketing and Administrative.

Culture at Metabolon

Step into our world, where we offer a glimpse into the heart of Metabolon. Experience how our culture nurtures creativity, supports growth, and fosters an environment where every individual’s unique contribution is valued and celebrated.

Kim Swift – Passion

Dive into Kim Swift’s world in this captivating video as she shares her thoughts on her role and why she is so passionate about working for Metabolon. With infectious enthusiasm, Kim explains how supporting clients and their research not only fuels innovation but also encourages continuous learning and growth.

Annie Evans – Purpose

In this inspiring video, Annie Evans takes us on a journey through her career, highlighting how a strong sense of purpose has driven her every step of the way. Through her experiences, she shows us the transformative power of aligning our work with our values, and how this connection can lead to both personal fulfillment and meaningful contributions to the world.

Josh Wilson – Performance

Join Josh Wilson in this insightful video as he delves into the realm of performance and career excellence. Drawing from his own professional journey, Josh emphasizes how a dedication to performance not only yields tangible results but also fosters a sense of accomplishment.

Our Values

Our team has a shared commitment to being the best at what we do and to make a positive impact. These are the characteristics of our values that are central to how we show up each day:

Purpose

We do what it takes every day to enable scientific discoveries that make a difference to support human health and the life sciences.

Performance

We are committed to hard work and success through collaboration at every level.

Passion

Our shared devotion to making a difference unites the contributions of every individual.
Values

Become a Metabolite

Our Benefits

Feel Good

  • Robust benefits, including medical plan options (PPO and HDHP), dental, vision, flexible spending accounts, life and disability benefits plus a partial deductible reimbursement.
  • Company HSA contribution
  • RTP “home office” site amenities such as subsidized snack station, gym, workout classes, beautiful walking paths, on-site car detailing, and food trucks
  • Fun at work such as company social events and team-building activities

Invest in you

  • Competitive total rewards and compensation
  • Onboarding and integration support
  • Retirement plans and company match
  • Career development via our customized Grow@Metabolon program to provide transparent career tracks across the organization and enable career growth across both technical and managerial paths.
  • Training workshops
  • Mentoring

Live your life

  • Robust PTO program*
  • A hybrid work environment
  • Paid parental leave

AT METABOLON, WE ARE COMMITTED TO:

Belonging

  • Diversity, Inclusion and Belonging
  • Mentorship
  • Onboarding and Integration

Internal Community

  • Company Events
  • Holiday Events
  • Shoutouts and Internal Recognition
R

Wellbeing

  • Wellness Challenges
  • Physical and Mental Wellness Initiatives

External Community

  • Philanthropy and Volunteering Events
  • Patient Focus
  • School and University Engagement

Work at Metabolon

Our team has a shared commitment to being the best at what we do and to make a positive impact. These are the characteristics of our values that are central to how we show up each day:

“I joined the Culture@Metabolon committee and find the purpose very meaningful to create a sense of community within our hybrid/remote work environment.”

Careers

Interested in a Sales Career at Metabolon?

REMOTE – HYBRID – ONSITE

Learn more about what a career in sales at Metabolon looks like, and check out all of our open remote, hybrid, and onsite positions!

Metabolon recognized as a Great Place To Work 2023-2024

Metabolon Named a Great Place To Work® for 2023-2024

At Metabolon, we believe in a supportive workplace that values and invests in our associates. Our employees believe in our technology and mission to provide metabolomics solutions that advance a wide variety of applications. We are proud to be certified as a Great Place to Work® for 2023-2024 achieving an 83% rating from employees which is 26% higher than the US-based average.

Metabolon is an Equal Opportunity Employer and does not discriminate against any employee or applicant for employment because of race, color, religion, gender, sexual orientation, gender identity, national origin, age, disability, veteran status or any other protected status prohibited under Federal, State or local laws. All employment decisions are based on valid job related requirements.

If you are a qualified individual with a disability or a disabled veteran and are unable or limited in your ability to use or access our website, you may request a reasonable accommodation to express interest in a specific opening. You can request accommodation by sending an email to HR@metabolon.com.

Please be aware that unauthorized parties may attempt to use the Metabolon name and logo, as well as the names of Metabolon employees, in emails and on websites to solicit up-front fees or to gather personal information from interested parties. Learn more about these recruiting scams.

*Certain rules and applications apply depending on non-exempt and international employees.

References

1. Zgoda-Pols, J.R., et al., Metabolomics analysis reveals elevation of 3-indoxyl sulfate in plasma and brain during chemically-induced acute kidney injury in mice: investigation of nicotinic acid receptor agonists. Toxicol Appl Pharmacol, 2011. 255(1): p. 48-56.

2. Bryant, J.A., et al., The impact of an oral purified microbiome therapeutic on the gastrointestinal microbiome. Nat Med, 2026. 32(1): p. 186-196

3. McGovern, B .H., et al., SER-109, an Investigational Microbiome Drugto Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial. Clin Infect Dis, 2021. 72(12): p. 2132-2140.

4. Feuerstadt, P., et al., SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection. N Engl J Med, 2022. 386(3): p. 220-229.

5. Hu, Z., et al., Targeted metabolomics reveals novel diagnostic biomarkers for colorectal cancer. Mol Oncol, 2025. 19(6): p. 1737-1750.

6. Butler, F.M., et al., Vegetarian Dietary Patterns and Diet-Related Metabolites Are Associated With Kidney Function in the Adventist Health Study-2 Cohort. J Ren Nutr, 2025.

7. Stanford, J., et al., Metabolomic Profiling and Diet Quality Scoring in a Randomized Crossover Trial of Healthy and Typical Dietary Patterns. Mol Nutr Food Res, 2025 . 69(23): p. e70271.

8. O’Connor, L.E., et al., Metabolomic Profiling of an Ultraprocessed Dietary Pattern in a Domiciled Randomized Controlled Crossover Feeding Trial. J Nutr, 2023. 153(8): p. 2181-2192.

9. Fritsch, D.A., et al., Microbiome function underpins the efficacy of a fiber-supplemented dietary intervention in dogs with chronic large bowel diarrhea. BMC Vet Res, 2022. 18(1): p. 245.

10. Leal, L.N., et al., Preweaning nutrient supply improves lactation productivity and reduces the risk of culling in Holstein cows. J Dairy Sci, 2025. 108(6): p. 5875-5888.

11. Ahsin, M., et al., Soil and pasture health underlie improved beef nutrient density determined by untargeted metabolomics in Southern US grass finished beef systems. NPJ Sci Food, 2025. 9(1): p. 151.

12. Yin, W., et al., Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemia. J Lipid Res, 2012. 53(1): p. 51-65.

13. Porter, F .D., et al., Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease. Sci Transl Med, 2010. 2(56): p. 56ra81.

14. Needham, B .D., et al., Plasma and Fecal Metabolite Profiles in Autism Spectrum Disorder. Biol Psychiatry, 2021. 89(5): p. 451-462

15. Li, C., et al., Estradiol and mTORC2 cooperate to enhance prostaglandin biosynthesis and tumorigenesis in TSC2-deficient LAM cells. J Exp Med, 2014. 211(1): p. 15-28.

16. Green, P.G., et al., Metabolic flexibility and reverse remodelling of the failing human heart. Eur Heart J, 2025. 46(25): p. 2422-2433.

17. Maekawa, H., et al., SGLT2 inhibition protects kidney function by SAM-dependent epigenetic repression of inflammatory genes under metabolic stress. J Clin Invest, 2025. 135(19).

18. Wu, D., et al., Integrated screens reveal that guanine nucleotide depletion, which is irreversible via targeting IMPDH2, inhibits pancreatic cancer and potentiates KRAS inhibition. Gut, 2026.

19. Schwerdtfeger, L.A., et al., Gut microbiota and metabolites are linked to disease progression in multiple sclerosis. Cell Rep Med, 2025. 6(4): p. 102055.

20. Wu, H., et al., Microbiome-metabolome dynamics associated with impaired glucose control and responses to lifestyle changes. Nat Med, 2025. 31(7): p. 2222-2231.

21. Jacobs, J.P., et al., Cognitive behavioral therapy for irritable bowel syndrome induces bidirectional alterations in the brain-gut-microbiome axis associated with gastrointestinal symptom improvement. Microbiome, 2021. 9(1): p. 236.

22. Pietzner, M., et al., Plasma metabolites to profile pathways in noncommunicable disease multimorbidity. Nat Med, 2021. 27(3): p. 471-479.

23. Faquih, T.O., et al., Robust Metabolomic Age Prediction Based on a Wide Selection of Metabolites. J Gerontol A Biol Sci Med Sci, 2025. 80(3).

24. Scherer, N., et al., Coupling metabolomics and exome sequencing reveals graded effects of rare damaging heterozygous variants on gene function and human traits. Nat Genet, 2025. 57(1): p. 193-205.

25. Holmes, Z.C., et al., Untargeted metabolomic analysis of human milk from healthy mothers reveals drivers of metabolite variability. Sci Rep, 2024. 14(1): p. 20827.

26. Titz, B., et al., Implications of Ocular Confounding Factors for Aqueous Humor Proteomic and Metabolomic Analyses in Retinal Diseases. Transl Vis Sci Technol, 2024. 13(6): p. 17.

27. Bloom, S.M., et al., Cysteine dependence of Lactobacillus iners is a potential therapeutic target for vaginal microbiota modulation. Nat Microbiol, 2022. 7(3): p. 434-450.

28. Leimer, E.M., et al., Lipid profile of human synovial fluid following intra-articular ankle fracture. J Orthop Res, 2017. 35(3): p. 657-666.